Iris A. Schulkens

709 total citations
16 papers, 465 citations indexed

About

Iris A. Schulkens is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Iris A. Schulkens has authored 16 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Immunology and 3 papers in Oncology. Recurrent topics in Iris A. Schulkens's work include Galectins and Cancer Biology (7 papers), Protein Tyrosine Phosphatases (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Iris A. Schulkens is often cited by papers focused on Galectins and Cancer Biology (7 papers), Protein Tyrosine Phosphatases (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Iris A. Schulkens collaborates with scholars based in Netherlands, United Kingdom and Sweden. Iris A. Schulkens's co-authors include Victor L. Thijssen, Arjan W. Griffioen, Roy Heusschen, Kitty C. M. Castricum, Hakon Leffler, Lonneke Duijkers, Peter Adamson, Anna Brugulat-Panés, Wouter Beumer and Katarina Jovanović and has published in prestigious journals such as PLoS ONE, American Journal Of Pathology and International Journal of Cancer.

In The Last Decade

Iris A. Schulkens

16 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iris A. Schulkens Netherlands	10	314	192	85	60	41	16	465
Bart Krist Poland	9	217 0.7×	123 0.6×	79 0.9×	119 2.0×	21 0.5×	11	434
Lauren Van Der Kraak Canada	9	186 0.6×	98 0.5×	149 1.8×	53 0.9×	89 2.2×	13	392
Guillermo Garaulet Spain	7	208 0.7×	87 0.5×	100 1.2×	56 0.9×	52 1.3×	13	458
Karen L. Singer United States	7	274 0.9×	166 0.9×	31 0.4×	43 0.7×	34 0.8×	7	527
Emily M. King United States	11	356 1.1×	110 0.6×	94 1.1×	29 0.5×	73 1.8×	16	589
Hannah Titheradge United Kingdom	9	297 0.9×	158 0.8×	61 0.7×	91 1.5×	80 2.0×	19	433
Marta Doménech Spain	11	165 0.5×	60 0.3×	140 1.6×	127 2.1×	77 1.9×	31	410
Sara Droetto Italy	11	278 0.9×	124 0.6×	59 0.7×	33 0.6×	71 1.7×	11	492
Nelson R. Salgado United States	4	267 0.9×	127 0.7×	117 1.4×	30 0.5×	24 0.6×	5	480
Susanne Bryde Netherlands	7	196 0.6×	100 0.5×	65 0.8×	27 0.5×	16 0.4×	7	435

Countries citing papers authored by Iris A. Schulkens

Since Specialization

Citations

This map shows the geographic impact of Iris A. Schulkens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris A. Schulkens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris A. Schulkens more than expected).

Fields of papers citing papers by Iris A. Schulkens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris A. Schulkens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris A. Schulkens. The network helps show where Iris A. Schulkens may publish in the future.

Co-authorship network of co-authors of Iris A. Schulkens

This figure shows the co-authorship network connecting the top 25 collaborators of Iris A. Schulkens. A scholar is included among the top collaborators of Iris A. Schulkens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris A. Schulkens. Iris A. Schulkens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Buffa, Francesca M., Kitty C. M. Castricum, Syed Haider, et al.. (2021). Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation. Journal of Experimental & Clinical Cancer Research. 40(1). 161–161. 22 indexed citations

Sanjurjo, Lucía, Iris A. Schulkens, Roy Heusschen, et al.. (2021). Chemokines modulate glycan binding and the immunoregulatory activity of galectins. Communications Biology. 4(1). 1415–1415. 8 indexed citations

Dulla, Kalyan, Iris A. Schulkens, Wouter Beumer, et al.. (2019). QR-421a, an antisense oligonucleotide, for the treatment of retinitis pigmentosa due to USH2A exon 13 mutations. Investigative Ophthalmology & Visual Science. 60(9). 3250–3250. 8 indexed citations

Dulla, Kalyan, Mònica Aguilà, Amelia Lane, et al.. (2018). Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models. Molecular Therapy — Nucleic Acids. 12. 730–740. 126 indexed citations

Schulkens, Iris A., Roy Heusschen, Kitty C. M. Castricum, et al.. (2018). Different angioregulatory activity of monovalent galectin-9 isoforms. Angiogenesis. 21(3). 545–555. 61 indexed citations

Biasutto, Patricia, Kalyan Dulla, Peter Adamson, et al.. (2017). QR-110 Treatment for Leber’s Congenital Amaurosis Type 10: Restoration of CEP290 mRNA Levels and Ciliation in LCA10 iPSC-Derived Optic Cups. Investigative Ophthalmology & Visual Science. 58(8). 249–249. 1 indexed citations

Fokas, Emmanouil, Philip D. Allen, Veerle Kersemans, et al.. (2016). Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect. Oncotarget. 7(47). 76613–76627. 22 indexed citations

Beijnum, Judy R. van, Victor L. Thijssen, Tilman Läppchen, et al.. (2016). A key role for galectin‐1 in sprouting angiogenesis revealed by novel rationally designed antibodies. International Journal of Cancer. 139(4). 824–835. 22 indexed citations

Punt, Simone, Jeanine J. Houwing‐Duistermaat, Iris A. Schulkens, et al.. (2015). Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer. Molecular Cancer. 14(1). 71–71. 39 indexed citations

10.

Schulkens, Iris A., et al.. (2014). Examination of the Role of Galectins and Galectin Inhibitors in Endothelial Cell Biology. Methods in molecular biology. 1207. 285–291. 5 indexed citations

11.

Schulkens, Iris A., Kitty C. M. Castricum, Ester M. Weijers, et al.. (2014). Expression, Regulation and Function of Human Metallothioneins in Endothelial Cells. Journal of Vascular Research. 51(3). 231–238. 37 indexed citations

12.

Schulkens, Iris A., Roy Heusschen, Robert‐Jan van Suylen, et al.. (2014). Galectin Expression Profiling Identifies Galectin-1 and Galectin-9Δ5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer. PLoS ONE. 9(9). e107988–e107988. 27 indexed citations

13.

Schulkens, Iris A., et al.. (2014). Examination of the Role of Galectins During In Vivo Angiogenesis Using the Chick Chorioallantoic Membrane Assay. Methods in molecular biology. 1207. 305–315. 8 indexed citations

14.

Punt, Simone, Iris A. Schulkens, Victor L. Thijssen, et al.. (2014). A high IL6/IL17 ratio combined with low IL5 expression is correlated with poor survival in squamous cervical cancer. Journal for ImmunoTherapy of Cancer. 2(S3). 2 indexed citations

15.

Heusschen, Roy, et al.. (2013). Endothelial LGALS9 splice variant expression in endothelial cell biology and angiogenesis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(2). 284–292. 54 indexed citations

16.

Dassen, H., Chamindie Punyadeera, Bert Delvoux, et al.. (2010). Olfactomedin-4 Regulation by Estrogen in the Human Endometrium Requires Epidermal Growth Factor Signaling. American Journal Of Pathology. 177(5). 2495–2508. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact